Predictability of designs which adjust for imbalances in prognostic factorsBARBACHANO, Yolanda; COAD, D. Stephen; ROBINSON, Derek R et al.Journal of statistical planning and inference. 2008, Vol 138, Num 3, pp 756-767, issn 0378-3758, 12 p.Article

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancerPOPAT, Sanjay; BARBACHANO, Yolanda; ASHLEY, Sue et al.Lung cancer. 2008, Vol 59, Num 2, pp 227-231, issn 0169-5002, 5 p.Article

Longitudinal Assessment of Quality of Life in Rectal Cancer Patients With or Without Stomas Following Primary ResectionYAU, Thomas; WATKINS, David; CUNNINGHAM, David et al.Diseases of the colon & rectum. 2009, Vol 52, Num 4, pp 669-677, issn 0012-3706, 9 p.Conference Paper

Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancerMURTHY, Vedang; NORMAN, Andrew R; BARBACHANO, Yolanda et al.BJU international (Papier). 2007, Vol 99, Num 6, pp 1380-1382, issn 1464-4096, 3 p.Article

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)DEWDNEY, Alice; CUNNINGHAM, David; YU JO CHUA et al.Journal of clinical oncology. 2012, Vol 30, Num 14, pp 1620-1627, issn 0732-183X, 8 p.Article

Prospective Study of Factors Predicting Adherence to Medical Advice in Men With Testicular CancerMOYNIHAN, Clare; NORMAN, Andy R; BARBACHANO, Yolanda et al.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2144-2150, issn 0732-183X, 7 p.Article

Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based populationAHMED, Merina; BARBACHANO, Yolanda; RIDDELL, Angela et al.European journal of endocrinology. 2011, Vol 165, Num 2, pp 315-322, issn 0804-4643, 8 p.Article

Long-Term Neurologic and Peripheral Vascular Toxicity After Chemotherapy Treatment of Testicular CancerGLENDENNING, Jennifer L; BARBACHANO, Yolanda; NORMAN, Andy R et al.Cancer. 2010, Vol 116, Num 10, pp 2322-2331, issn 0008-543X, 10 p.Article

Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neckROGERS, Susanne J; BOX, Carol; CHAMBERS, Philip et al.Journal of pathology (Print). 2009, Vol 218, Num 1, pp 122-130, issn 0022-3417, 9 p.Article

DOSE-ESCALATED INTENSITY-MODULATED RADIOTHERAPY IS FEASIBLE AND MAY IMPROVE LOCOREGIONAL CONTROL AND LARYNGEAL PRESERVATION IN LARYNGO-HYPOPHARYNGEAL CANCERSMIAH, Aisha B; BHIDE, Shreerang A; NURSING, DiP et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 539-547, issn 0360-3016, 9 p.Article

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyMITRA, Anita V; BANCROFT, Elizabeth K; EVANS, D. G et al.BJU international (Papier). 2011, Vol 107, Num 1, pp 28-39, issn 1464-4096, 12 p.Article

Overexpression of RAD51 occurs in aggressive prostatic cancerMITRA, Anita; JAMESON, Charles; EASTON, Douglas et al.Histopathology. 2009, Vol 55, Num 6, pp 696-704, issn 0309-0167, 9 p.Article